BlackRock Inc. - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 33 filers reported holding SATSUMA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$93,078
-24.1%
133,256
-2.2%
0.00%
Q4 2022$122,671
-86.6%
136,300
-10.4%
0.00%
Q3 2022$913,000
+60.7%
152,180
+10.9%
0.00%
Q2 2022$568,000
+11.6%
137,240
+2.3%
0.00%
Q1 2022$509,000
-25.3%
134,131
-11.3%
0.00%
Q4 2021$681,000
-3.0%
151,253
+0.4%
0.00%
Q3 2021$702,000
-20.6%
150,706
+20.2%
0.00%
Q2 2021$884,000
-74.4%
125,374
-78.5%
0.00%
Q1 2021$3,448,000
+30.7%
583,519
+1.9%
0.00%
Q4 2020$2,638,000
+24.2%
572,515
+4.8%
0.00%
Q3 2020$2,124,000
-86.6%
546,119
-1.0%
0.00%
-100.0%
Q2 2020$15,856,000
+244.9%
551,366
+158.1%
0.00%
Q1 2020$4,597,000
+42.9%
213,612
+30.6%
0.00%
Q4 2019$3,218,000
+257.6%
163,533
+172.7%
0.00%
Q3 2019$900,00059,9700.00%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders